In the News: UVA Health Efforts to Curb COVID-19
See the latest press releases to learn how UVA Health is making an impact in the midst of this global health crisis.
Telehealth Tools Developed for Ebola Improve COVID Care
The telehealth tools allow doctors to provide personal, high-quality care while conserving vital personal protective equipment and reducing infection risks.
UVA Health Reopens for In-Person Care
UVA Health is ramping up access to both inpatient and outpatient care with robust safety measures in place to protect the health of patients and team members.
UVA Health Trial to Test Convalescent Plasma as Potential COVID-19 Treatment
UVA Health is launching a clinical trial to test the effectiveness of using plasma from patients that have recovered from COVID-19 as a potential treatment for inpatients with the disease.
Drug Tested at UVA Cleared as 1st COVID-19 Treatment
The federal Food and Drug Administration has issued emergency-use authorization for the antiviral drug, remdesivir, the first treatment authorized to battle the life-threatening illness.
COVID-19: Drug Tested at UVA Speeds Recovery
The antiviral drug remdesivir, tested against COVID-19 at UVA Health and other sites, helped patients with advanced cases recover 31% faster than patients who received a placebo, the National Institutes of Health reports.
UVA Health Enacting Changes in Response to COVID-19 Financial Impact
UVA Health is implementing a series of actions designed to mitigate the financial effects of COVID-19 and safeguard its ability to serve the community.
Covid-19 and Imaging: Why CT Scans and X-Rays Are Not Recommended for Diagnosing Coronavirus
Lab testing for COVID-19 remains limited in many places. Because of this, some healthcare providers have turned to chest CT scans or x-rays to diagnose COVID-19. However, current evidence suggests that these tools are not specific enough to either diagnose or rule out the virus.
Exercise May Help Prevent Deadly Complication of COVID-19
Regular exercise may reduce the risk of acute respiratory distress syndrome, a major cause of death in patients with the COVID-19 virus, a top UVA exercise researcher reports.
A Robot Is Allowing UVA Health to Reuse Thousands of Masks in COVID-19 Fight
The robot, called “Tru-D,” uses ultraviolet germicidal irradiation (UV) or UV light vectors to disinfect porous and non-porous surfaces without toxic chemicals.
UVA Joins National Trial to Test Potential COVID-19 Medication
The trial will evaluate the safety and effectiveness of remdesivir, an antiviral drug that has been tested in humans with Ebola virus.
Newly Developed COVID-19 Testing
UVA’s current testing platform enables more than 100 tests per day, and the health system has offered to perform up to 50 tests per day for hospitals across Virginia on behalf of inpatients that meet clinical guidelines for testing.
More COVID-19 News from UVA
Updated: May 11, 2020